C’elle: “Caring is Sharing”
When I got diagnosed with cancer sometime ago, the idea of stem cells was a fairly new one. In fact, information about it was not as widespread as it is now. Moreover, it was a very expensive option and a risky one at that since harvesting stem cells required invasive procedures. Bottomline, it wasn’t easily accessible to everyone.
I’ve already written about the revolutionary stem cell research and technology by Cryo-Cell in this blog. They offer women a non-invasive process of collecting stem cells from their menstrual blood right in the privacy of their homes. These are then processed and preserved for medical, cosmetic or other cellular therapies in the future. While research and clinical trials for this technology is still underway, preliminary studies have demonstrated that menstrual stem cells “are a novel cell population that may be routinely and safely isolated and provide renewable source of stem cells from child-bearing women,” according to Julie Allickson, Ph.D. of Cryo-Cell International. An April 14, 2008 report by the company also found out that menstrual cells are “stromal cells, meaning they have the capability to differentiate into important cells, such as bone, cartilage, fat, nerve and cardiogenic cells. The study also found out that the cells divided rapidly and plentifully, indicating a possible therapeutic value.” More exciting is the preliminary finding that indicates that aside from the donor, stem cells may also benefit other familiy members who are genetically related to her. This new technology thus empowers women in more ways than one, allowing her to take control of her health and her future.
With this, C’elle is now holding a for a limited time, the “Caring is Sharing” promo. “A woman can purchase C’elle for herself and give a meaningful gift of life to her best friend, sister or loved one for free. To purchase C’elle online go to www.Celle.com and use special promotion code: 241.”
Click on C’elle Client Testimonial to learn more about this exciting health innovation.
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a Reply